Showing results (1571-1580 of 12,170) with videos related to

Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|August 13, 1998
T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytesS Hoischen, K Brixius, R H Schwinger
Journal of Cardiovascular Pharmacology|June 20, 2012
Effects of spironolactone alone and in addition to a β-blocker on myocardial histological and electrical remodeling in chronic severe failing rat heartsPaul Milliez, Sophie Gomes, Laure Champ-Rigot, et al.
Journal of Cardiovascular Pharmacology|September 11, 1998
Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarctionK Yoshida, M Kohzuki, D J Casley, et al.
Journal of Cardiovascular Pharmacology|September 11, 1998
Evidence for constitutive release of nitric oxide in the venous circuit of pigsS Magder, K Kabsele
Journal of Cardiovascular Pharmacology|September 11, 1998
ACE insertion/deletion genotype affects bradykinin metabolismN J Brown, C Blais, S K Gandhi, et al.
Journal of Cardiovascular Pharmacology|September 11, 1998
Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycinL Eckardt, W Haverkamp, H Mertens, et al.
Journal of Cardiovascular Pharmacology|September 11, 1998
Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heartB Le Grand, B Vié, G W John
Journal of Cardiovascular Pharmacology|September 11, 1998
17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogsY D Kim, M Y Farhat, A K Myers, et al.
Journal of Cardiovascular Pharmacology|September 11, 1998
Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogsS S Rebello, J Huang, W J Shiu, et al.
Pageof 1,217